COMMUNIQUÉS West-GlobeNewswire

Philips presents results from 3-year telehealth program impacting over 100,000 patients across Europe
02/04/2019
April 2, 2019 Advancing Care Coordination & Telehealth Deployment at Scale ( ACT@Scale ) Handbook now available to implement and grow population health management to improve patient care and reduce costs in an aging [...]
Lexington Biosciences Provides Update on Financial Situation
02/04/2019
VANCOUVER, British Columbia, April 02, 2019 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announced on February 14, 2019 that it had been unable to secure the [...]
Community Health Network decides for C-RAD’s innovative SIGRT solution
02/04/2019
C-RAD and Community Health Network announced today an agreement to equip three of their cancer centers located in the state of Indiana with C-RAD’s surface tracking solution based on Catalyst and Sentinel 4DCT. [...]
LIDDS announces a novel TLR9 agonist project and plan for Phase I clinical trial
02/04/2019
Clinical data shows that intratumoral delivery of TLR agonists in combination with immune checkpoint inhibitors can effectively treat solid cancers. NanoZolid® technology is very suitable to provide sustained [...]
Curetis Introduces Unyvero AMR Atlas to Support Adoption of Rapid DNA Testing for Antibiotic Resistance
02/04/2019
Knowledge base of antimicrobial resistance (AMR) markers tailored specifically to Unyvero Applications Developed by Curetis’ subsidiary Ares Genetics and powered by ARESdb Initial focus on Unyvero Pneumonia Applications [...]
Novartis first-in-class Cosentyx® approved in China for psoriasis patients
02/04/2019
China Health Authority NMPA approved Cosentyx ® (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy Cosentyx is the first biologic approved in [...]
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin
02/04/2019
Approved for Use in the Treatment of Primary Humoral Immunodeficiency Disease (“PIDD” or “PI”) in Adults and Adolescents (12 to 17 Years of Age) FDA Approval Triggers Funding up to $27.5M from Existing Credit Facility [...]
MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS
02/04/2019
LA JOLLA, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
BriaCell Announces Closing of Upsized & Oversubscribed Non-Brokered Private Placement of $2.97 Million
02/04/2019
BERKELEY, Calif., and VANCOUVER, British Columbia, April 01, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
Akers Biosciences Reports Fiscal Year 2018 Earnings
01/04/2019
Ongoing Measures to Streamline Operations, Reduce Costs and Position the Company for Strategic Alternatives THOROFARE, N.J., April 01, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the [...]
Hemispherx Reports 2018 Year-end Financial Results
01/04/2019
OCALA, Fla., April 01, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announces financial results for the fiscal year ended December 31, 2018, and provides a business update. Highlights of 2018 [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
01/04/2019
EMERYVILLE, Calif., April 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it has issued inducement awards to five new [...]
DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F
01/04/2019
Montrouge, France, April 1, 2019 DBV Technologies Announces Filing of 2018 “Document de Référence” and 2018 Annual Report on Form 20-F DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies Publie son Document de Référence 2018 et son « Form 20-F » américain
01/04/2019
Montrouge, France, le 1 avril (23 :00 CET) 2019 DBV Technologies Publie son Document de Référence 2018 et son « Form 20-F » américain DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]
EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results
01/04/2019
Reports record revenues for the fifth consecutive year Record fiscal year 2018 revenues of €39.2 million Q4 2018 HIFU net sales increased 79% year-over-year Profitable and cash flow positive during the fourth quarter of [...]
Daré Bioscience, Inc. Regains Listing Compliance on Nasdaq
01/04/2019
SAN DIEGO, April 01, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health innovation, today announced that it received notice from The Nasdaq Stock Market LLC indicating that the [...]
Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update
01/04/2019
Conference call and webcast scheduled for tomorrow, Tuesday, April 2, at 8:30 am Eastern Time GAITHERSBURG, Md., April 01, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics [...]
Supernus Announces Webcast of Investor Day on April 16, 2019
01/04/2019
ROCKVILLE, Md., April 01, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Precision Therapeutics Reports Year End 2018 Financial Results and Provides Corporate Update
01/04/2019
MINNEAPOLIS, April 01, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to Women’s Oncology, announced today [...]

Pages